Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
sciences in research and teaching. The following full-time, permanent position is available in the central IT infrastructure of the centre from the earliest possible date: IT engineer (f/m/d) with a focus on
-
collaborate. In this context, the following full-time, permanent position is to be filled at COS Heidelberg in the central IT infrastructure from 1 January 2026: IT engineer (f/m/d) with a focus on operations
-
infrastructure. The position entails active involvement in both experimental procedures and computational data analysis, alongside the improvement of advanced methodologies, including single-cell proteomics
-
University and at the Heidelberg University of Jewish Studies (depending on PhD supervision), the following positions (65%) for up to 3+1 years are to be filled by 1 April 2026: 12 pre-doctoral research
-
relevant experience in management and administration in a similar position; knowledge of the structures of large research groups and university administration Experience in drafting manuscripts and research
-
funding acquisition, and international research experience in the field. The future holder of the position is expected to competently and strategically develop the Department of Gerontopsychiatry and
-
the field. Participation in international scientific networks in genomics is expected. The future holder of the position is expected to competently and strategically strengthen the scientific orientation
-
place particular emphasis on counteracting this imbalance. If they have the same aptitude, qualifications and professional performance, we give priority to people with severe disabilities when considering
-
The following position at the Heidelberg Center for Ibero-American Studies (HCIAS) of Heidelberg University, Germany, is to be filled as soon as possible: Postdoctoral researcher (f/m/d) Part or
-
University, one of Europe’s leading biomedical institutions. This position focuses on unraveling the regulatory networks underlying dormancy and therapy resistance in acute myeloid leukemia (AML). Using